학술논문

First clinical Experience of Isatuximab Safety and Tolerability in relapsed and refractory Multiple Myeloma (RRMM): Real-world Data from a Compassionate Use Program in Germany
Document Type
Journal
Source
ONCOLOGY RESEARCH AND TREATMENT; OCT 3 2023, 46 p315-p316, 2p. Supplement: 5
Subject
Language
English
ISSN
22965262